irofulven has been researched along with B16 Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, SF; Dexter, DL; Kelner, MJ; MacDonald, JR; Mangold, GL; McMorris, TC; Muscoplat, CC; Von Hoff, DD | 1 |
1 other study(ies) available for irofulven and B16 Melanoma
Article | Year |
---|---|
Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin S.
Topics: Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Drug Screening Assays, Antitumor; Female; HT29 Cells; Humans; Leukemia P388; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Nude; Sesquiterpenes; Transplantation, Heterologous | 1997 |